TAFINLAR vs TECENTRIQ

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. TAFINLAR and TECENTRIQ are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	TAFINLAR	TECENTRIQ
Rating	70/100	70/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	DABRAFENIB MESYLATE	ATEZOLIZUMAB
Manufacturer	Novartis	Genentech Inc
Dosage forms	Capsule, Tablet	Injectable
Drug class	—	—
Boxed warning	None	None
Treats	Melanoma	Urinary Bladder Neoplasms, Non-Small-Cell Lung Carcinoma, Hepatocellular Carcinoma

tafinlar tecentriq

Rating

70/100

Pharmacy pays

—

Type

Active ingredient

DABRAFENIB MESYLATE

ATEZOLIZUMAB

Manufacturer

Novartis

Genentech Inc

Dosage forms

Capsule, Tablet

Injectable

Drug class

—

Boxed warning

None

Treats

Melanoma

Urinary Bladder Neoplasms, Non-Small-Cell Lung Carcinoma, Hepatocellular Carcinoma

Frequently asked questions

Which is better-rated, Tafinlar or Tecentriq?

Tafinlar and Tecentriq are tied at 3.5 out of 5 by our independent rating.

What is the difference between Tafinlar and Tecentriq?

Tafinlar contains Dabrafenib Mesylate, while Tecentriq contains Atezolizumab — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.